Trial Profile
Surgery +/- interferon alpha-2b in patients with facial nodular or solid basal cell cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2013
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Basal cell cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Sep 2013 New trial record